Syndel’s Syncaine® approved in the UK

On March 22, 2022, Syndel's tricaine methanesulfonate (MS-222) fish anesthetic Syncaine® received a Marketing Authorization from the United Kingdom's Veterinary Medicines Directorate (VMD). 

Syncaine®, formally known as Tricaine-S and Aqualife TMS, is manufactured at Syndel's new US production facility.  Since its initial US FDA approval in 1997, Syndel's Tricaine has become a recognized and highly regarded fish anesthetic that is widely used in the global aquaculture industry. 
 

Image credit: Flickr
(CC BY-SA 2.0)

Founded in 1972, Syndel is dedicated to delivering fish health solutions for the aquaculture Industry. From Syndel's head office located in Ferndale, Washington USA, Syndel manufactures and markets a portfolio of products that are specifically dedicated to fish health, nutrition, reproduction, and biosecurity. 

For more information, visit the Syndel website, HERE.

The Aquaculturists

---